49 Wealth Management’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

49 Wealth Management’s Portfolio FRLN Stock Details FRLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-15,519	Closed	-$98.9K	–	140
2023 Q4	$98.9K	Buy	+15,519	New	+$83.1K	0.03%	116

49 Wealth Management's FRLN Position: Q1 2024 in Review

49 Wealth Management sold out of Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) in Q1 2024, closing a stake of 15,519 shares — an estimated $98.9K sold.

49 Wealth Management first reported a position in FRLN in Q4 2023 and held it in 1 quarter. The position peaked at $98.9K in Q4 2023. 0 funds tracked by Wall St. Rank hold FRLN as of Q1 2024.

49 Wealth Management reported no remaining Freeline Therapeutics Holdings plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
49 Wealth Management sold 15,519 Freeline Therapeutics Holdings plc American Depositary Shares shares in Q1 2024, an estimated $98.9K.
49 Wealth Management first reported a position in Freeline Therapeutics Holdings plc American Depositary Shares in Q4 2023 and held it in 1 quarter.
49 Wealth Management's Freeline Therapeutics Holdings plc American Depositary Shares position peaked at $98.9K in Q4 2023.
0 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings plc American Depositary Shares as of Q1 2024.

Based on 49 Wealth Management's 13F filing for Q1 2024, filed 7 May 2024.